劉婷婷
長庚醫療財團法人高雄長庚紀念醫院
國語,英語,閩南語 助理教授
肝臟病理，移植病理、胃腸病理
劉婷婷看診時間
| 星期一 | 24 小時營業 |
| 星期二 | 24 小時營業 |
| 星期三 | 24 小時營業 |
| 星期四 | 24 小時營業 |
| 星期五 | 24 小時營業 |
| 星期六 | 24 小時營業 |
| 星期日 | 24 小時營業 |
劉婷婷醫師簡介
現職
- 助理教授級主治醫師/副主任
學歷
- 慈濟大學醫學系, 2010
經歷
- 2016.10~ 高雄長庚紀念醫院解剖病理科主治醫師
- 2014.08~2016.09 高雄長庚紀念醫院檢驗醫學科住院醫師
- 2010.08~2014.07 高雄長庚紀念醫院解剖病理科住院醫師
學會與認證
- 台灣病理學會
- 台灣臨床病理檢驗醫學會
論文及期刊發表
- Liu TT, Li CF, Tan KT, Jan YH, Lee PH, Huang CH, Yu SC, Tsao CF, Wang JC and Huang HY*. Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of H2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers 2022 Mar 31;14(7):1787.
- Lee PH, Weng SW, Liu TT, Yu HL, Wang MC, Huang WT. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment. Exp Mol Pathol 2019 Oct;110:104294.
- Wu CN, Liu TT, Yang CH, Hwang CF Current and future treatments for external auditory canal cancer. International Journal of Head and Neck Science 2019, 3(2): 78-91.
- You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Co-First author)
- Li CF, Liu TT, Wang JC, Yu SC, Chen YY, Fang FM, Li Ws, Huang HY. Hydroxysteroid 11- dehydrogenase 1 overexpression with copy-number gain and missense mutations in primary gastrointestinal stromal tumors. J Clin Med. 2018 Nov 1;7(11). pii: E408. doi: 10.3390/jcm7110408 (SCI, IF=5.583; General & internal, co-first author*)
- Li CF, Liu TT, Chuang IC, Chen YY, Fu-Min Fang FM, Chan TC, Li WS, Huang HY. PLCB4 copy gain and PLCs4 overexpression in primary gastrointestinal stromal tumors: integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival. Oncotarget. 2017 Mar 21;8(12):19997-20010
- Huang GK, Liu TT, Weng SW, You HL, Wei YC, Chen CH, Eng HL, Huang WT. CUL4A Overexpression as an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. BMC Cancer (2017) 17:395 DOI 10.1186/s12885-017-3389-z (Co-first author)
- Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.
APMIS 2016 Mar 14;124(3):216-20.
Ting-Ting Liu, Shao-Wen Weng, Ming-Chung Wang, Wan-Ting Huang*. - Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma.
PLoS One. 2015 Dec 18;10(12)
Ting-Ting Liu, Huey-Ling You, Shao-Wen Weng, Yu-Ching Wei, Hock-Liew Eng and Wan-Ting Huang*.